Capital Advantage, Inc. - Q2 2017 holdings

$382 Million is the total value of Capital Advantage, Inc.'s 74 reported holdings in Q2 2017. The portfolio turnover from Q1 2017 to Q2 2017 was 15.7% .

 Value Shares↓ Weighting
BSCI SellGugg. Corp. Bullet 2018$55,843,000
-0.5%
2,627,902
-0.6%
14.63%
-4.8%
IEFA SelliShares Core MSCI EAFE$32,683,000
+4.2%
536,755
-0.8%
8.56%
-0.3%
BSJH SellGugg. HY Bullet 2017$21,544,000
-1.5%
837,652
-1.5%
5.64%
-5.7%
MGV SellVanguard Mega Cap Value ETF$13,068,000
-20.6%
188,403
-21.5%
3.42%
-24.0%
SLY SelliShares S&P 600 Index$11,834,000
-0.1%
168,789
-1.5%
3.10%
-4.4%
VXUS SellVanguard Total International S$9,594,000
+1.6%
184,598
-2.9%
2.51%
-2.8%
MGC SellVanguard Mega Cap Blend ETF$5,981,000
-30.8%
72,159
-32.6%
1.57%
-33.8%
MDY SellSPDR S&P MidCap 400 ETF$4,709,000
-11.0%
14,825
-12.5%
1.23%
-14.9%
AAPL SellApple, Inc.$3,681,000
-2.1%
25,559
-2.3%
0.96%
-6.3%
VCSH SellVanguard Short Term Corp Bond$2,834,000
-1.0%
35,410
-1.3%
0.74%
-5.2%
IVV SelliShares S&P 500 Index$2,644,000
-67.3%
10,861
-68.1%
0.69%
-68.7%
BRKB SellBerkshire Hathaway Cl B$2,062,000
-13.2%
12,175
-14.6%
0.54%
-17.1%
CVX SellChevron Corp$1,914,000
-4.3%
18,347
-1.5%
0.50%
-8.4%
GE SellGeneral Electric$1,575,000
-12.3%
58,325
-3.2%
0.41%
-16.1%
SCHM SellSchwab US Mid-Cap ETF$1,473,000
-4.0%
30,582
-5.7%
0.39%
-8.1%
T SellAT&T$1,449,000
-13.1%
38,408
-4.3%
0.38%
-16.8%
SCHX SellSchwab US Large-Cap ETF$1,290,000
-47.8%
22,322
-49.1%
0.34%
-50.0%
SCHF SellSchwab International Equity ET$1,055,000
-14.3%
33,189
-19.5%
0.28%
-18.1%
MSFT SellMicrosoft Corp$1,036,000
-6.2%
15,025
-10.4%
0.27%
-10.6%
PFE SellPfizer Incorporated$822,000
-1.9%
24,465
-0.1%
0.22%
-6.5%
UTX SellUnited Technologies Corp.$814,000
-2.0%
6,670
-10.0%
0.21%
-6.6%
VOO SellVanguard S&P 500 Index ETF$790,000
-66.8%
3,557
-67.7%
0.21%
-68.3%
PG SellProcter & Gamble Co$685,000
-18.6%
7,859
-16.1%
0.18%
-22.5%
SellIntel Corp$645,000
-12.2%
19,105
-6.2%
0.17%
-15.9%
MRK SellMerck & Co Inc$609,000
-5.1%
9,506
-5.9%
0.16%
-9.1%
AMZN SellAmazon.com Inc.$612,000
-30.4%
632
-36.2%
0.16%
-33.6%
CSCO SellCisco Systems$593,000
-25.3%
18,931
-19.4%
0.16%
-28.6%
HON SellHoneywell International$562,000
+5.6%
4,213
-1.1%
0.15%
+0.7%
MCD SellMcDonalds Corp$553,000
+15.9%
3,611
-1.9%
0.14%
+10.7%
PEP SellPepsico Incorporated$458,000
+2.0%
3,965
-1.2%
0.12%
-2.4%
IBM SellInternational Business Machine$386,000
-26.6%
2,508
-17.0%
0.10%
-29.9%
VIG SellVanguard Div Appreciation$384,000
-12.7%
4,147
-15.2%
0.10%
-16.5%
BA SellBoeing Co$331,000
+11.1%
1,674
-0.7%
0.09%
+6.1%
MO SellAltria$313,000
-22.5%
4,199
-25.7%
0.08%
-26.1%
VTI SellVanguard Total Stock Market ET$309,000
-21.6%
2,479
-23.6%
0.08%
-25.0%
PSX SellPhillips 66$297,000
-24.4%
3,590
-27.7%
0.08%
-27.8%
SCHO SellSchwab ST US Treasury ETF$262,000
-1.5%
5,196
-1.5%
0.07%
-5.5%
DIS SellWalt Disney Co$254,000
-30.4%
2,390
-25.7%
0.07%
-33.0%
KO SellCoca Cola Company$248,000
+1.6%
5,540
-3.8%
0.06%
-3.0%
VFH SellVanguard Financials ETF$233,000
-23.6%
3,720
-26.2%
0.06%
-27.4%
HD SellHome Depot$227,000
-8.5%
1,480
-12.2%
0.06%
-13.2%
QCOM SellQualcomm Inc$217,000
-11.1%
3,928
-7.6%
0.06%
-14.9%
AXP SellAmerican Express Co$215,000
+4.9%
2,558
-1.5%
0.06%0.0%
VEA ExitVanguard FTSE Developed Market$0-5,136
-100.0%
-0.06%
DOW ExitDow Chemical Company$0-3,403
-100.0%
-0.06%
JPM ExitJ P Morgan Chase & Co$0-2,594
-100.0%
-0.06%
DUK ExitDuke Energy$0-2,831
-100.0%
-0.06%
SYK ExitStryker Corp$0-1,994
-100.0%
-0.07%
PM ExitPhilip Morris Intl Inc$0-2,443
-100.0%
-0.08%
SCHE ExitSchwab Emerging Market Equity$0-27,632
-100.0%
-0.18%
IEMG ExitiShares Core MSCI Emerging Mar$0-118,907
-100.0%
-1.56%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2017-08-08
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
Microsoft Corp39Q3 20231.2%
Chevron Corp39Q3 20231.0%
Facebook Inc Class A39Q3 20231.3%
AT&T Inc39Q3 20230.6%
Pfizer Incorporated39Q3 20230.3%
Cisco Systems Inc39Q3 20230.3%
Verizon Communications Inc39Q3 20230.3%
iShares Russell 2000 ETF38Q2 20231.4%
Vanguard Dividend Appreciation ETF37Q3 20238.4%
Merck & Co Inc37Q2 20230.4%

View Capital Advantage, Inc.'s complete holdings history.

Latest filings
TypeFiled
13F-HR2024-05-14
13F-HR2024-01-23
13F-HR2023-10-30
13F-HR2023-08-07
13F-HR2023-05-05
13F-HR2023-01-24
13F-HR2022-10-31
13F-HR2022-07-21
13F-HR2022-05-10
13F-HR2022-01-21

View Capital Advantage, Inc.'s complete filings history.

Compare quarters

Export Capital Advantage, Inc.'s holdings